Acura Pharma (ACUR) Misses Q1 EPS by 4c
Get Alerts ACUR Hot Sheet
Join SI Premium – FREE
Acura Pharma (NASDAQ: ACUR) reported Q1 EPS of $0.03, $0.04 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $5.4 million versus the consensus estimate of $7.6 million.
For earnings history and earnings-related data on Acura Pharma (ACUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alcoa (AA) Misses Q1 EPS by 19c
- First Bancorp (FNLC) Reports Q1 EPS of $0.54
- Cohen & Steers (CNS) Misses Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!